KCT0000914
Recruiting
未知
A 8 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of IRT5 probiotics on atopic dermatitis in children
Korea Yakult Corporation0 sites110 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the skin and subcutaneous tissue
- Sponsor
- Korea Yakult Corporation
- Enrollment
- 110
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)subject who signs ICF with a legal representative who signs the informed consent form before participating in the study
- •2\)subject aged between 5 years and 12 years with atopic dermatitis
- •3\)subject with intermittent or continuous atopic dermatits symptom over 6 months
- •4\)subject with SCORAD index between 25 and 50
Exclusion Criteria
- •1\)subject with other systemic illnesses or dermatits history except AD
- •2\)subject administrating immunosuppressant,antobiotics,corticosteroid, antihistaminic within 4 weeks
- •3\)subject who has taken medicines,chinese medicine, health functional foods within 4 weeks for improvement of atopic dermatitis
- •4\)subject with systemic phototherapy within 1 month
- •5\)subject with probiotics within 2 weeks
- •6\)subject who has taken scheduled for participating in another study during this study period or who had participated in other study within 4 weeks
- •7\)Inappropriate subject decided by investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
APGP for the evaluation of efficacy on immune function and immune cell activatioNot ApplicableKCT0002551Yonsei University100
Completed
Not Applicable
A 8 week, randomized, double-blind, placebo-controlled clinical trial of Enzymatic Hydrolysate of Skipjack Tuna Cooking Drip for the evaluation of efficacy and safety on immune functioNot ApplicableKCT0002136Yonsei University100
Completed
Not Applicable
Clinical trial for the evaluation of the efficacy and safety of live or killed Lactobacillus sakei Probio65 on atopic dermatitis in childreDiseases of the skin and subcutaneous tissueKCT0003928Probionic90
Completed
Not Applicable
The efficacy and safety of weissella cibaria CMU on halitosisDiseases of th respiratory systemKCT0003301Dankook University60
Recruiting
Not Applicable
The efficacy and safety of oraCMU on oral healthKCT0004291Seoul National University Dental Hospital100